Cargando…

Long-Term Outcome and Complications of IOL-Exchange

PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Märker, David A, Radeck, Viola, Barth, Teresa, Helbig, Horst, Scherer, Nicolas C D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625384/
https://www.ncbi.nlm.nih.gov/pubmed/37927577
http://dx.doi.org/10.2147/OPTH.S436963
_version_ 1785131121575460864
author Märker, David A
Radeck, Viola
Barth, Teresa
Helbig, Horst
Scherer, Nicolas C D
author_facet Märker, David A
Radeck, Viola
Barth, Teresa
Helbig, Horst
Scherer, Nicolas C D
author_sort Märker, David A
collection PubMed
description PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treating ophthalmologists were reviewed. Visual outcomes and any occurring complications after the IOL exchange were analyzed. RESULTS: IOL exchange was performed in 48 eyes of 46 patients and significantly improved best-corrected distance visual acuity from 0.42 ± 0.32 logMar (mean ± SD) in opacified lenses to 0.25 ± 0.28 logMar after IOL exchange. Nine of the 48 eyes (19%) underwent 11 further surgical procedures for complications due to four indications: IOL dislocation (n = 2, 4%), retinal detachment (RD) (n = 6, 12%), epiretinal membrane (n = 2, 4%), and pupillary block (n = 1, 2%). Three eyes (6%) developed a temporarily elevated intraocular pressure. Temporary postoperative cystoid macular edema was found in 2 eyes (4%). CONCLUSION: IOL exchange can restore vision owing to IOL opacification in most cases. Nonetheless, IOL exchange is not an easy or risk-free procedure. This may lead to sight-threatening complications, even in eyes without predisposing ocular comorbidities.
format Online
Article
Text
id pubmed-10625384
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106253842023-11-05 Long-Term Outcome and Complications of IOL-Exchange Märker, David A Radeck, Viola Barth, Teresa Helbig, Horst Scherer, Nicolas C D Clin Ophthalmol Original Research PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treating ophthalmologists were reviewed. Visual outcomes and any occurring complications after the IOL exchange were analyzed. RESULTS: IOL exchange was performed in 48 eyes of 46 patients and significantly improved best-corrected distance visual acuity from 0.42 ± 0.32 logMar (mean ± SD) in opacified lenses to 0.25 ± 0.28 logMar after IOL exchange. Nine of the 48 eyes (19%) underwent 11 further surgical procedures for complications due to four indications: IOL dislocation (n = 2, 4%), retinal detachment (RD) (n = 6, 12%), epiretinal membrane (n = 2, 4%), and pupillary block (n = 1, 2%). Three eyes (6%) developed a temporarily elevated intraocular pressure. Temporary postoperative cystoid macular edema was found in 2 eyes (4%). CONCLUSION: IOL exchange can restore vision owing to IOL opacification in most cases. Nonetheless, IOL exchange is not an easy or risk-free procedure. This may lead to sight-threatening complications, even in eyes without predisposing ocular comorbidities. Dove 2023-10-31 /pmc/articles/PMC10625384/ /pubmed/37927577 http://dx.doi.org/10.2147/OPTH.S436963 Text en © 2023 Märker et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Märker, David A
Radeck, Viola
Barth, Teresa
Helbig, Horst
Scherer, Nicolas C D
Long-Term Outcome and Complications of IOL-Exchange
title Long-Term Outcome and Complications of IOL-Exchange
title_full Long-Term Outcome and Complications of IOL-Exchange
title_fullStr Long-Term Outcome and Complications of IOL-Exchange
title_full_unstemmed Long-Term Outcome and Complications of IOL-Exchange
title_short Long-Term Outcome and Complications of IOL-Exchange
title_sort long-term outcome and complications of iol-exchange
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625384/
https://www.ncbi.nlm.nih.gov/pubmed/37927577
http://dx.doi.org/10.2147/OPTH.S436963
work_keys_str_mv AT markerdavida longtermoutcomeandcomplicationsofiolexchange
AT radeckviola longtermoutcomeandcomplicationsofiolexchange
AT barthteresa longtermoutcomeandcomplicationsofiolexchange
AT helbighorst longtermoutcomeandcomplicationsofiolexchange
AT scherernicolascd longtermoutcomeandcomplicationsofiolexchange